v3.25.1

Discontinued operations and assets held for sale (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Discontinued operations and assets held for sale |
Schedule of consideration received | ​
​ | ​ | ​ | ​
​ |  | Year ended December 31, 2024
​ | ​ | (Euro, in thousands)
Upfront payment received | ​ | € | 50,000
Settlement for net cash and working capital | ​ | ​ | 9,835
Total consideration received | ​ | € | 59,835
Schedule of assets and liabilities over which control was lost | ​
​ | ​ | ​ | ​
​ |  | January 31, 2024
​ | ​ | (Euro, in thousands)
Property, plant and equipment | ​ | € | 4,186
Deferred tax assets | ​ | ​ | 292
Other non-current assets | ​ | ​ | 613
Inventories | ​ | ​ | 505
Trade and other receivables | ​ | ​ | 18,439
Cash and cash equivalents | ​ | ​ | 19,523
Other current assets | ​ | ​ | 1,161
Total assets | ​ | ​ | 44,719
​ | ​ | ​ | ​
Other reserves | ​ | ​ | (74)
Retirement benefit liabilities | ​ | ​ | 1,003
Non-current lease liabilities | ​ | ​ | 2,328
Other non-current liabilities | ​ | ​ | 90
Current lease liabilities | ​ | ​ | 1,308
Trade and other liabilities | ​ | ​ | 28,927
Current tax payable | ​ | ​ | 1,170
Current deferred income | ​ | ​ | 430
Total liabilities | ​ | ​ | 35,182
​ | ​ | ​ | ​
Net assets disposed of | ​ | € | 9,537
Schedule of gain or loss on disposal of subsidiaries. | ​
​ | ​ | ​ | ​
​ |  | Year ended December 31, 2024
​ | ​ | (Euro, in thousands)
Upfront payment received | ​ | € | 50,000
Settlement for net cash and working capital | ​ | ​ | 9,835
Additional adjustment working capital to be settled | ​ | ​ | (750)
Net assets disposed of | ​ | ​ | (9,537)
Effect of cumulative translation adjustments reclassified from equity on loss of control | ​ | ​ | (4,095)
Fair value of the future earn-outs payable by Alfasigma to us | ​ | ​ | 47,035
Contribution for R&D costs payable by us to Alfasigma | ​ | ​ | (40,000)
Gain on disposal of subsidiaries | ​ | € | 52,488
Schedule of net cash flow on disposal of subsidiaries | ​
​ | ​ | ​ | ​
Upfront payment received |  | € | 50,000
Settlement for net cash and working capital | ​ | ​ | 9,835
Transfer to escrow account | ​ | ​ | (40,000)
Contribution for R&D costs paid by us to Alfasigma | ​ | ​ | (15,000)
Earn-outs paid by Alfasigma | ​ | ​ | 2,053
Less: cash and cash equivalents balances disposed of | ​ | ​ | (19,523)
Less: settlement of pre-existing relationships | ​ | ​ | 3,686
Cash out from disposals of subsidiaries, net of cash disposed of | ​ | € | (8,949)
​ | ​ | ​ | ​
​ | ​ | ​ | ​
​ | ​ | ​ | ​
Costs associated to the sale taken into result in 2023 | ​ | € | (3,072)
Costs associated to the sale taken into result in 2024 | ​ | ​ | (526)
Cash used for other liabilities related to the disposal of subsidiaries | ​ | € | (3,598)
Schedule of financial statements in relation to the discontinued operations | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended December 31,
​ |  | 2024 |  | 2023 |  | 2022
​ | ​ | (Euro, in thousands, except share and per share data)
Product net sales | ​ | € | 11,475 | ​ | € | 112,339 | ​ | € | 87,599
Collaboration revenues | ​ | ​ | 26,041 | ​ | ​ | 431,465 | ​ | ​ | 176,432
Total net revenues | ​ | ​ | 37,516 | ​ | ​ | 543,804 | ​ | ​ | 264,031
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cost of sales | ​ | ​ | (1,693) | ​ | ​ | (18,022) | ​ | ​ | (12,079)
Research and development expenses | ​ | ​ | (8,152) | ​ | ​ | (190,177) | ​ | ​ | (245,286)
Sales and marketing expenses | ​ | ​ | (11,520) | ​ | ​ | (113,356) | ​ | ​ | (144,075)
General and administrative expenses | ​ | ​ | (1,087) | ​ | ​ | (17,989) | ​ | ​ | (9,776)
Other operating income | ​ | ​ | 56,180 | ​ | ​ | 13,003 | ​ | ​ | 10,721
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating profit/loss (-) | ​ | ​ | 71,244 | ​ | ​ | 217,262 | ​ | ​ | (136,464)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Fair value adjustments and net currency exchange differences | ​ | ​ | — | ​ | ​ | (13) | ​ | ​ | (25)
Other financial income | ​ | ​ | 4,230 | ​ | ​ | 679 | ​ | ​ | 15
Other financial expenses | ​ | ​ | (12) | ​ | ​ | (167) | ​ | ​ | (7,825)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Profit/loss (-) before tax | ​ | ​ | 75,462 | ​ | ​ | 217,761 | ​ | ​ | (144,298)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income taxes | ​ | ​ | (98) | ​ | ​ | (2,076) | ​ | ​ | (2,272)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net profit/loss (-) | ​ | € | 75,364 | ​ | € | 215,685 | ​ | € | (146,570)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Basic and diluted earnings/loss (-) per share from discontinued operations | ​ | € | 1.14 | ​ | € | 3.27 | ​ | € | (2.23)
Weighted average number of shares (in thousands of shares) | ​ | ​ | 65,897 | ​ | ​ | 65,884 | ​ | ​ | 65,699
Weighted average number of shares - Diluted (in thousands of shares) | ​ | ​ | 65,942 | ​ | ​ | 65,933 | ​ | ​ | 65,699
Schedule of cash flow from discontinued operations. | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2024 |  | 2023 |  | 2022
​ | ​ | (Euro, in thousands)
Net cash flow used in operating activities | ​ | € | (36,367) | ​ | € | (175,627) | ​ | € | (191,095)
Net cash flow used in investing activities | ​ | ​ | (8,949) | ​ | ​ | (105) | ​ | ​ | (136)
Net cash flow used in financing activities | ​ | ​ | — | ​ | ​ | (1,928) | ​ | ​ | (1,841)
Net cash flow used in discontinued operations | ​ | € | (45,316) | ​ | € | (177,660) | ​ | € | (193,072)
​

X
- Definition Tabular disclosure of assets and liabilities over which control was lost. + References No definition available. + Details
Name: | glpg_DisclosureOfAssetsAndLiabilitiesOverWhichControlWasLostTableTextBlock
Namespace Prefix: | glpg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the analysis of cash flow from discontinued operations. + References No definition available. + Details
Name: | glpg_DisclosureOfCashFlowFromDiscontinuedOperations
Namespace Prefix: | glpg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of gain or loss on disposal of subsidiaries. + References No definition available. + Details
Name: | glpg_DisclosuresOfGainOrLossOnDisposalOfSubsidiaries
Namespace Prefix: | glpg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of consideration received from disposal of subsidiary. + References No definition available. + Details
Name: | glpg_ScheduleOfDisclosureOfConsiderationReceivedFromDisposalOfSubsidiary
Namespace Prefix: | glpg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of net cash flow on disposal of subsidiaries. + References No definition available. + Details
Name: | glpg_ScheduleOfNetCashFlowOnDisposalOfSubsidiariesTableTextBlock
Namespace Prefix: | glpg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the analysis of the single amount of discontinued operations. [Refer: Discontinued operations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2024-01-01 -Paragraph 33 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration